A new trend in insulin pricing? Here’s what you need to know.
Insulin pricing has been a topic of concern and debate in recent years, as prices have skyrocketed, making it difficult for many patients with diabetes to afford the medication they need. However, the following recent announcements from major
pharmaceutical manufacturers—who make up about 90% of the insulin market—Eli Lilly, Novo Nordisk, and Sanofi, indicate a promising trend towards more affordable insulin prices.
Download our guide to get a summary of the changes from Eli Lilly, Novo Nordisk, and Sanofi and what plan sponsors need to know.
